Oral Oncology
Volume 40, Issue 8 , Pages 798-803 , September 2004

Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue

Received 16 October 2003 ,Accepted 18 December 2003.

References 

  1. Cummings CW, Fredrickson JM, Harker LA, et al.  Otolaryngology head and neck surgery. 3rd ed.. St Louis, CV: Mosby; 1998;
  2. Spiro RH, Huvos AG, Wong GY, et al.  Predictive value of tumor thickness in squamous cell carcinoma confined to the tongue and floor of mouth. Am. J. Surg. 1986;152:345–350
  3. Fidler IJ. Molecular biology of cancer: invasion and metastasis. In:  DeVita VT,  Hellman S,  Rosenberg SA editor. Cancer: principles and practice of oncology. 5th ed.. Philadelphia: Lippincott-Raven; 1997;p. 135–152
  4. Chambers AF, Matrisian L. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 1997;89:1260–1270
  5. Kahari VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumor growth and invasion. Ann. Med. 1999;31:34–45
  6. Ray JM, Stetler-Stevenson WG. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO. 1995;14:908–917
  7. Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 1999;43(Suppl S):42–51
  8. Zatterstrom UK, Brun E, Willen R, et al.  Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck. 1995;17:312–318
  9. Shpitzer T, Chaimoff M, Gal R. Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch. Otolaryngol. Head Neck Surg. 1996;122:865–868
  10. Lochter A, Bissell MJ. An odyssey from breast to bone: multi-step control of mammary metastases and osteolysis by matrix metalloproteinases. APMIS. 1999;107:128–136
  11. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl. J. Med. 1995;333:1757–1763
  12. Thomas GT, Lewis MP, Speight PM. Matrix metalloproteinases and oral cancer. Oral Oncol. 1999;35:227–233
  13. O-charoenrat P, Rhys-Evans P, Modjtahedi H, et al.  Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int. J. Cancer. 2000;86:307–317
  14. Imren S, Kohn DB, Shimada H, et al.  Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res. 1996;56:2891–2895
  15. Charous SJ, Stricklin GP, Nanney LB, et al.  Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann. Otol. Rhinol. Laryngol. 1997;106:271–278
  16. Ikebe T, Shinohara M, Takeuchi H, et al.  Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin. Exp. Metastasis. 1999;17:315–323
  17. O-charoenrat P, Rhys-Evans P, Eccles S. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 2001;127:813–820
  18. Bertaux B, Hornebeck W, Eisen AZ, et al.  Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J. Invest. Dermatol. 1991;97:679–685
  19. Lynch CC, Matzisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation. 2002;70:561–573
  20. Hollingsworth HC, Hohn EC, Steinberg SM, et al.  Tumor angiogenesis in advanced stage ovarian carcinoma. Am. J. Pathol. 1995;147:33–41
  21. Tanigawa N, Amaya H, Matsumura M, et al.  Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinoma. Cancer Res. 1996;56:2671–2676
  22. Graham CH, Rivers J, Robert SK, et al.  Extent of vascularization as a prognostic indicator in thin malignant melanomas. Am. J. Pathol. 1994;145:510–514
  23. Tanigawa N, Matsumura M, Amaya H, et al.  Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer. 1997;79:220–225

PII: S1368-8375(04)00009-0

doi: 10.1016/j.oraloncology.2004.01.006

Oral Oncology
Volume 40, Issue 8 , Pages 798-803 , September 2004

Article Tools

* Image Usage & Resolution